Perceptive Advisors LLC 13D and 13G filings for Coherus Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | COHERUS ONCOLOGY, INC. CHRS | Perceptive Advisors LLC | 0 0.000% | -5,407,798 (Position Closed) | Filing |
| 2022-02-14 6:33 pm Purchase | 2021-12-31 | 13G | COHERUS ONCOLOGY, INC. CHRS | Perceptive Advisors LLC | 5,407,798 7.000% | 735,962 (+15.75%) | Filing |